Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PROPYLTHIOURACIL 50 MG TABLET

PROPYLTHIOURACIL
$0.2724per EA

Strength

50 mg/1

Manufacturer

Quagen Pharmaceuticals LLC

NDC

70752017110

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PROPYLTHIOURACIL

Approval Type

Generic (ANDA)

FDA Application

ANDA080154

On Market Since

3/18/2021

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price History

1W

0.0%

1M

-1.6%

3M

-3.0%

6M

-6.0%

1Y

-7.2%

3Y

-42.5%

5Y

-44.5%

All

-44.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

METHIMAZOLE 5 MG TABLET
Generic
00832607211•Upsher-Smith Laboratories LLC
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
23155007001•Heritage Pharmaceuticals Inc.
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
33342033511•Macleods Pharmaceuticals Limited
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
60687066901•American Health Packaging
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
62135020518•Chartwell RX LLC
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
62135020590•Chartwell RX LLC
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
64380021201•Strides Pharma Inc.
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
64380021202•Strides Pharma Inc.
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
64980026401•Rising Pharma Holdings Inc.
$0.0718
per EA
METHIMAZOLE 5 MG TABLET
Generic
69452032820•Bionpharma Inc.
$0.0718
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy